<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154859">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02096991</url>
  </required_header>
  <id_info>
    <org_study_id>BPA-CAN-1</org_study_id>
    <nct_id>NCT02096991</nct_id>
  </id_info>
  <brief_title>Associations of Exposure to Bisphenol A With Blood Pressure and Epigenetic Change</brief_title>
  <official_title>Associations of Exposure to Bisphenol A With Blood Pressure and Epigenetic Change</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Republic of Korea: Ministry of Health and Welfare</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Bisphenol A(BPA) is an endocrine disrupting chemical, which mimics the action of
           estrogen.

        -  Previous studies reported that BPA exposure is associated with increased risk of
           cardiovascular diseases.

        -  Exposure to BPA occur mainly through oral route, and epoxy coating of canned food is
           one of the well established source.

        -  The investigators hypothesis is that increased BPA exposure from canned beverage would
           disrupt normal physiology in a short term.

        -  In the present trial the investigators are to investigate whether increased BPA
           exposure by consuming canned beverage actually affect cardiovascular indices and
           epigenetic feature.

        -  For this aim, the investigators will conduct a cross-over trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>2 hours after consuming beverage</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent DNA methylation</measure>
    <time_frame>2 hours after consuming the beverage</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variablility</measure>
    <time_frame>2 hours after consuming the beverage</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Glass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>consume beverage in glass first and cross over to other interventions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Can 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consume one canned beverage and a glass bottled beverage first and cross over to other interventions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Can 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consume two canned beverage first and cross over to other interventions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Can 1</intervention_name>
    <description>drink the beverage in a can and a glass bottle</description>
    <arm_group_label>Glass</arm_group_label>
    <arm_group_label>Can 1</arm_group_label>
    <arm_group_label>Can 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Can 2</intervention_name>
    <description>Consume two canned beverage</description>
    <arm_group_label>Glass</arm_group_label>
    <arm_group_label>Can 1</arm_group_label>
    <arm_group_label>Can 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glass</intervention_name>
    <description>consume two glass bottled beverage</description>
    <arm_group_label>Glass</arm_group_label>
    <arm_group_label>Can 1</arm_group_label>
    <arm_group_label>Can 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reside in Seoul

          -  Who provided Informed consent

        Exclusion Criteria:

          -  Who has cancer

          -  Who has disease or disorder of liver, nervous system, endocrine system,
             cardiovascular system

          -  Who does not provieded informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun-Chul Hong, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Preventive Medicine, College of Medicine, Seoul National University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Preventive Medicine, College of Medicine, Seoul National University</name>
      <address>
        <city>Seoul</city>
        <zip>110-799</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 23, 2014</lastchanged_date>
  <firstreceived_date>February 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yun-Chul Hong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methamphetamine</mesh_term>
    <mesh_term>Bisphenol A</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
